Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters

被引:23
|
作者
Seitz, S
Werner, S
Fischer, J
Nothnagel, A
Schlag, PM
Scherneck, S
机构
[1] Max Delbruck Ctr Mol Med, Dept Tumor Genet, D-13122 Berlin, Germany
[2] Robert Roessle Hosp, Dept Med Informat, D-13122 Berlin, Germany
[3] Robert Roessle Hosp, Dept Surg & Surg Oncol, D-13122 Berlin, Germany
关键词
breast cancer; chromosomal region 8p12-p21; loss of heterozygosity; clinicopathological parameters;
D O I
10.1016/S0959-8049(00)00135-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have further refined the loss of heterozygosity (LOH) pattern on the human chromosomal region 8p12-p21 using 15 well characterised microsatellite markers in a panel of 50 breast carcinomas. The allelic loss pattern of these rumours suggests the presence of five commonly deleted regions on 8p12-p21. The most commonly deleted region was located between markers D8S1734 and D81989, spanning a distance of approximately 3 cM and reaching 56% LOH at locus NEFL. LOH at 8p12-p21 was significantly correlated with large tumour size (T > 5 cm). Patients with the age at diagnosis of breast cancer between 45 and 55 years showed significantly more LOH than patients older than 55 years or younger than 45 years. No correlation was observed between 8p12-p21 alterations and histological tumour type, grade and the presence of lymph node metastases. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1507 / 1513
页数:7
相关论文
共 50 条
  • [31] Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
    Chenjie Zeng
    Xingyi Guo
    Jirong Long
    Karoline B. Kuchenbaecker
    Arnaud Droit
    Kyriaki Michailidou
    Maya Ghoussaini
    Siddhartha Kar
    Adam Freeman
    John L. Hopper
    Roger L. Milne
    Manjeet K. Bolla
    Qin Wang
    Joe Dennis
    Simona Agata
    Shahana Ahmed
    Kristiina Aittomäki
    Irene L. Andrulis
    Hoda Anton-Culver
    Natalia N. Antonenkova
    Adalgeir Arason
    Volker Arndt
    Banu K. Arun
    Brita Arver
    Francois Bacot
    Daniel Barrowdale
    Caroline Baynes
    Alicia Beeghly-Fadiel
    Javier Benitez
    Marina Bermisheva
    Carl Blomqvist
    William J. Blot
    Natalia V. Bogdanova
    Stig E. Bojesen
    Bernardo Bonanni
    Anne-Lise Borresen-Dale
    Judith S. Brand
    Hiltrud Brauch
    Paul Brennan
    Hermann Brenner
    Annegien Broeks
    Thomas Brüning
    Barbara Burwinkel
    Saundra S. Buys
    Qiuyin Cai
    Trinidad Caldes
    Ian Campbell
    Jane Carpenter
    Jenny Chang-Claude
    Ji-Yeob Choi
    Breast Cancer Research, 18
  • [32] Population Genetic Analysis of the Association Between the BRCA1 and P53 Gene Polymorphisms and the Risk of Sporadic Breast Cancer
    V. A. Tarasov
    M. M. Aslanyan
    E. S. Tsyrendorzhiyeva
    R. F. Garkavtseva
    L. N. Lyubchenko
    Yu. P. Altukhov
    V. A. Mel’nik
    Russian Journal of Genetics, 2005, 41 : 913 - 921
  • [33] Association of Selected Polymorphisms of CCND1, p21, and caspase8 With Colorectal Cancer Risk
    Liu, Bing
    Zhang, Yongjing
    Jin, Mingjuan
    Ni, Qin
    Liang, Xia
    Ma, Xinyuan
    Yao, Kaiyan
    Li, Qilong
    Chen, Kun
    MOLECULAR CARCINOGENESIS, 2010, 49 (01) : 75 - 84
  • [34] Expression and clinicopathological significance of lipin-1 in human breast cancer and its association with p53 tumor suppressor gene
    Dinarvand, Negar
    Khanahmad, Hossein
    Hakimian, Sayyed Mohammadreza
    Sheikhi, Abdolkarim
    Rashidi, Bahman
    Bakhtiari, Hadi
    Pourfarzam, Morteza
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (7-8) : 5835 - 5846
  • [35] Study of the association between Urotensin 2 (p.T21M and p.S89N) variants and breast cancer in Egyptian patients
    Kamal, Asmaa
    Mohsen, Ahmed
    Kamal, Amr
    Siam, Ibrahem
    GENE REPORTS, 2020, 20
  • [36] STUDY OF EPIGENETIC ALTERATION OF THE PROMOTER REGION OF P16, BRCA1, GSTP1 GENES AND SPORADIC BREAST CANCER
    Varriale, E.
    Sangermano, A.
    Postiglione, L.
    Di Paolo, M.
    Tommaselli, A. P.
    Morelli, L.
    Dell'edera, D.
    WORLD CANCER RESEARCH JOURNAL, 2015, 2 (01)
  • [37] A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes
    Maria J Garcia
    Jessica C M Pole
    Suet-Feung Chin
    Andrew Teschendorff
    Ali Naderi
    Hilal Ozdag
    Maria Vias
    Tanja Kranjac
    Tatiana Subkhankulova
    Claire Paish
    Ian Ellis
    James D Brenton
    Paul A W Edwards
    Carlos Caldas
    Oncogene, 2005, 24 : 5235 - 5245
  • [38] Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy
    Tsuneizumi, M
    Emi, M
    Hirano, A
    Utada, Y
    Tsumagari, K
    Takahashi, K
    Kasumi, F
    Akiyama, F
    Sakamoto, G
    Kazui, T
    Nakamura, Y
    CANCER LETTERS, 2002, 180 (01) : 75 - 82
  • [39] Expression of the HER family mRNA in breast cancer tissue and association with cell cycle inhibitors p21waf1 and p27kip1
    Kalemi, Theodora G.
    Papazisis, Konstantincis T.
    Lambropoulos, Alexandros F.
    Voyatzi, Soultana
    Kotsis, Alexandros
    Kortsaris, Alexandros H.
    ANTICANCER RESEARCH, 2007, 27 (02) : 913 - 920
  • [40] Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
    Anne Letessier
    Fabrice Sircoulomb
    Christophe Ginestier
    Nathalie Cervera
    Florence Monville
    Véronique Gelsi-Boyer
    Benjamin Esterni
    Jeannine Geneix
    Pascal Finetti
    Christophe Zemmour
    Patrice Viens
    Emmanuelle Charafe-Jauffret
    Jocelyne Jacquemier
    Daniel Birnbaum
    Max Chaffanet
    BMC Cancer, 6